These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7395609)

  • 1. Bromocriptine therapy of hyperprolactinemic disorders.
    Friesen HG
    Adv Biochem Psychopharmacol; 1980; 23():147-54. PubMed ID: 7395609
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bromocriptine therapy of prolactinoma in pregnancy].
    Nehmzow M; Ventz M; Meng W
    Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine.
    Thorner MO; Evans WS; MacLeod RM; Nunley WC; Rogol AD; Morris JL; Besser GM
    Adv Biochem Psychopharmacol; 1980; 23():165-89. PubMed ID: 7395611
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of treatment in the hyperprolactinemic anovulatory syndrome].
    Justus B; Richter B; Seiler E; Held HJ; Köhler K; Schaps P
    Zentralbl Gynakol; 1985; 107(21):1296-9. PubMed ID: 4082817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 6. Ergot drugs in the treatment of endocrine disorders: introduction.
    Kleinberg DL; Frantz AG
    Adv Biochem Psychopharmacol; 1980; 23():143-6. PubMed ID: 7395608
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hyperprolactinemias: a matter of controversy.
    Carmina E; Jannì A
    Acta Eur Fertil; 1983; 14(4):241-7. PubMed ID: 6673443
    [No Abstract]   [Full Text] [Related]  

  • 8. [The results of using parlodel in hyperprolactinemia].
    Mel'nichenko GA; Gitel' EP; Romantsova TI
    Probl Endokrinol (Mosk); 1990; 36(3):29-33. PubMed ID: 2395828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Visual and neurological disturbances accompanying with pregnancies of hyperprolactinemic patients].
    Takahashi A; Su JH; Motohashi T; Horie K; Tojo S
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):665-73. PubMed ID: 6864025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperprolactinemia.
    Kemmann E; Jones JR
    Am Fam Physician; 1981 Mar; 23(3):119-24. PubMed ID: 7468401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy and the hyperprolactinemic woman.
    Molitch ME
    N Engl J Med; 1985 May; 312(21):1364-70. PubMed ID: 3887166
    [No Abstract]   [Full Text] [Related]  

  • 13. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and treatment of hyperprolactinemia].
    Kato Y; Shimazu A; Ota H; Kabayama Y; Matsunaga K
    Horumon To Rinsho; 1984 Jan; 32(1):27-32. PubMed ID: 6538822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 16. Disorders of prolactin secretion.
    Thorner MO
    J Clin Pathol Suppl (Assoc Clin Pathol); 1976; 7():36-41. PubMed ID: 1073164
    [No Abstract]   [Full Text] [Related]  

  • 17. Bromocriptine treatment of pituitary adenomas.
    Baskin DS; Wilson CB
    Neurosurgery; 1981 Jun; 8(6):741-4. PubMed ID: 7279165
    [No Abstract]   [Full Text] [Related]  

  • 18. [New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma].
    Geyer G
    Wien Med Wochenschr; 1980 Aug; 130(15-16):501-9. PubMed ID: 6258331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of prolactin release by methysergide and bromocriptine in hyperprolactinemic subjects: comparative dynamic studies (author's transl)].
    Fossati P; Dewailly D; Lemaire A; Cappoen JP; Wemeau JL; Fourlinnie JC; Linquette M
    Ann Endocrinol (Paris); 1980; 41(1):55-6. PubMed ID: 7396395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.